NCT02229747View on ClinicalTrials.gov

Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

February 28, 2002

Conditions
Pharyngitis
Interventions
DRUG

Meloxicam

DRUG

Diclofenac

DRUG

Nimesulide

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02229747 - Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis | Biotech Hunter | Biotech Hunter